Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy (Q39842438)

15 September 2017

title

Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy (English)

1 reference

15 September 2017

1 reference

1 reference

1 reference

D Boczkowski

1 reference

15 September 2017

J Lee

series ordinal

1 reference

15 September 2017

S Pruitt

series ordinal

1 reference

15 September 2017

S Nair

series ordinal

1 reference

15 September 2017

publication date

5 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

page(s)

900-911

1 reference

Cancer immunotherapy: moving beyond current vaccines

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

The therapeutic implications of intratumoral regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

In vivo sites and cellular mechanisms of T reg cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Immunostimulatory monoclonal antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

The role of the CTLA4 blockade in the treatment of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Improving the efficacy of antibody-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Vaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Synergy between tumor immunotherapy and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

7 January 2021

Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

7 January 2021

The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

7 January 2021

Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.39

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.39

1 reference

15 September 2017

1 reference